BIO-TECHNE Corp (TECH) FY2026 Annual P&L / Income Statement

BIO-TECHNE Corp (TECH) FY2026 Annual P&L / Income Statement

Income statement for 2025-07-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

1,215,039,000 US dollars

Cost of sales

415,968,000 US dollars

Gross margin

799,071,000 US dollars

Total operating expenses

547,181,000 US dollars

Operating income

251,890,000 US dollars

Total other income (expense), net

negative 11,210,000 US dollars

Earnings before income taxes

240,680,000 US dollars

Income taxes

58,818,000 US dollars

Net earnings

181,862,000 US dollars

Protein Sciences

874,620,000 US dollars

Diagnostics and Spatial Biology

336,365,000 US dollars

Undisclosed (calculated)

4,054,000 US dollars

Selling, general and administrative

452,415,000 US dollars

Research and development

94,766,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.